USER ID: 
 PASSWORD: 
Course Overview

Learning Objectives

Upon completion of this activity, participants should be able to:

  • Explain the debate over whether levodopa is potentially neurotoxic to remaining dopaminergic neurons in Parkinson’s disease
  • Recognize the range of motor complications caused by levodopa and the mechanism responsible for their development
  • Recognize the therapeutic usefulness of levodopa in the treatment of Parkinson’s disease
Help
1. Starting the Course
2. Login/Logout Procedures
3. Can’t See Video Clips of Presenters
4. For Further Assistance
Starting the Course
Describes the step-by-step process of beginning the course.
Starting the Course
To begin this course, you will need to complete a brief registration form. There is no cost to register. Upon completing the form, you may immediately login with your username and password that you created during the registration process. Once you login, you'll be able to start the course.
 
(c) 2006 The Movement Disorder Society & The Center for Advanced Medical Education. All rights reserved. Privacy Statement